BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15882786)

  • 1. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.
    Zhu H; Gopalraj RK; Kelly JF; Bennett DA; Estus S
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):36-41. PubMed ID: 15882786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease.
    Fidani L; Goulas A; Crook R; Petersen RC; Tangalos E; Kotsis A; Hardy J
    Neurosci Lett; 2004 Mar; 357(2):152-4. PubMed ID: 15036597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
    J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
    Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
    Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene.
    Horne BD; Carlquist JF; Cannon-Albright LA; Muhlestein JB; McKinney JT; Kolek MJ; Clarke JL; Anderson JL; Camp NJ
    Ann Hum Genet; 2006 Jul; 70(Pt 4):524-34. PubMed ID: 16759183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD; Camp NJ; Anderson JL; Mower CP; Clarke JL; Kolek MJ; Carlquist JF;
    J Am Coll Cardiol; 2007 May; 49(20):2053-60. PubMed ID: 17512363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.
    Winkelmann BR; Hoffmann MM; Nauck M; Kumar AM; Nandabalan K; Judson RS; Boehm BO; Tall AR; Ruaño G; März W
    Pharmacogenomics J; 2003; 3(5):284-96. PubMed ID: 14583798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
    Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
    Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients.
    Fidani L; Hatzitolios AI; Goulas A; Savopoulos C; Basayannis C; Kotsis A
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):102-5. PubMed ID: 15896905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the APP gene promoter region and risk of Alzheimer disease.
    Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
    Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
    Liu J; Zhao D; Liu S; Liu J; Qin LP; Wu ZS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):300-3. PubMed ID: 12820950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein.
    Borel P; Moussa M; Reboul E; Lyan B; Defoort C; Vincent-Baudry S; Maillot M; Gastaldi M; Darmon M; Portugal H; Lairon D; Planells R
    Br J Nutr; 2009 Mar; 101(5):680-7. PubMed ID: 18662427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians.
    Cellini E; Nacmias B; Olivieri F; Ortenzi L; Tedde A; Bagnoli S; Petruzzi C; Franceschi C; Sorbi S
    Mech Ageing Dev; 2005; 126(6-7):826-8. PubMed ID: 15888337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [I405V polymorphism of the cholesteryl ester transfer protein gene in young and very old individuals].
    Lucchi T; Arosio B; Caloni M; Ceconi I; Calabresi C; Scurati S; Vergani C
    Ann Ital Med Int; 2005; 20(1):45-50. PubMed ID: 15859394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.